COMPANY
FDA-cleared device company
Keywords: cardiovascular Tricuspid Regurgitation Tricuspid Regurgitation Functional Severe Tricuspid Valve Regurgitation
Location: Newtown, PA · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Not phased (device or behavioral study): The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US source ↗
- Trial start Not phased (device or behavioral study): Study of Transcatheter Tricuspid Annular Repair source ↗
Upcoming milestones
- 2027-06 (ESTIMATED) · Not phased · The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US · NCT06700239
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06700239 | The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US | Not phased (device or behavioral study) | Not yet recruiting | Dec 31, 2025 | 2027-06 (estimated) |
| NCT03692598 | Study of Transcatheter Tricuspid Annular Repair | Not phased (device or behavioral study) | Recruiting | 2016-12 | 2025-12 (estimated) |
